Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alleviation of Cedar Pollen Induced Allergic Symptoms by Orally Taken Superfine Beta-1,3-Glucan - A Double-Blind Randomized Study

NCT00276445 is registered in ClinicalTrials.gov with Meiji University of Oriental Medicine as lead sponsor.

NCT NCT00276445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00276445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alleviation of Cedar Pollen Induced Allergic Symptoms by Orally Taken Superfine Beta-1,3-Glucan - A Double-Blind Randomized Study
Lead sponsor
Meiji University of Oriental Medicine
Phase
Phase 4
Overall status
Terminated
Start date
January 31, 2004
Completion date
June 30, 2004
Enrollment
60
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic conjunctivitis